These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

102 related articles for article (PubMed ID: 23663655)

  • 41. Comment on Khunti et al. Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study. Diabetes care 2015;38:316-322.
    Giménez M; Amor AJ; Quirós C; Conget I
    Diabetes Care; 2015 Jun; 38(6):e91. PubMed ID: 25998305
    [No Abstract]   [Full Text] [Related]  

  • 42. Diabetes mellitus is associated with elevated risk of mortality amongst patients with prostate cancer: a meta-analysis of 11 cohort studies.
    Cai H; Xu Z; Xu T; Yu B; Zou Q
    Diabetes Metab Res Rev; 2015 May; 31(4):336-43. PubMed ID: 25066306
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Insulin therapy and cancer-specific mortality in patients with colorectal cancer and diabetes.
    Kesikli SA; Unluturk U; Kilickap S
    J Clin Oncol; 2012 May; 30(14):1729-30; author reply 1730-2. PubMed ID: 22493418
    [No Abstract]   [Full Text] [Related]  

  • 44. 25-Hydroxyvitamin D Status and Risk for Colorectal Cancer and Type 2 Diabetes Mellitus: A Systematic Review and Meta-Analysis of Epidemiological Studies.
    Ekmekcioglu C; Haluza D; Kundi M
    Int J Environ Res Public Health; 2017 Jan; 14(2):. PubMed ID: 28134804
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Metabolic abnormalities and risk for colorectal cancer in the physicians' health study.
    Stürmer T; Buring JE; Lee IM; Gaziano JM; Glynn RJ
    Cancer Epidemiol Biomarkers Prev; 2006 Dec; 15(12):2391-7. PubMed ID: 17164361
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The excess mortality related to cardiovascular diseases and cancer among adults pharmacologically treated for diabetes--the 2001-2006 ENTRED cohort.
    Romon I; Rey G; Mandereau-Bruno L; Weill A; Jougla E; Eschwège E; Simon D; Druet C; Fagot-Campagna A
    Diabet Med; 2014 Aug; 31(8):946-53. PubMed ID: 24627972
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Colorectal cancer].
    Mizoue T
    Nihon Rinsho; 2016 Apr; 74 Suppl 2():426-30. PubMed ID: 27266129
    [No Abstract]   [Full Text] [Related]  

  • 48. Authors' reply to editorial linked to their umbrella review of meta-analyses of observational studies on type 2 diabetes and cancer.
    Tsilidis KK; Ioannidis JP
    BMJ; 2015 Feb; 350():h711. PubMed ID: 25673332
    [No Abstract]   [Full Text] [Related]  

  • 49. Risk of colorectal cancer in type 2 diabetic patients: a population-based cohort study.
    Wang JY; Chao TT; Lai CC; Wang CY; Wu VC; Wang SM; Lin HI; Tang SH; Lin HW
    Jpn J Clin Oncol; 2013 Mar; 43(3):258-63. PubMed ID: 23288931
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Impact of diabetes mellitus and insulin use on survival after colorectal cancer diagnosis: the Cancer Prevention Study-II Nutrition Cohort.
    Dehal AN; Newton CC; Jacobs EJ; Patel AV; Gapstur SM; Campbell PT
    J Clin Oncol; 2012 Jan; 30(1):53-9. PubMed ID: 22124092
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The relationship between diabetes and colorectal cancer prognosis: A meta-analysis based on the cohort studies.
    Zhu B; Wu X; Wu B; Pei D; Zhang L; Wei L
    PLoS One; 2017; 12(4):e0176068. PubMed ID: 28423026
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Role of obesity in colorectal carcinogenesis].
    Hagymási K; Tulassay Z
    Orv Hetil; 2007 Dec; 148(51):2411-6. PubMed ID: 18055394
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A large scale population-based cohort study on the risk of ovarian neoplasm in patients with type 2 diabetes mellitus.
    Chen HF; Chang YH; Ko MC; Li CY
    Gynecol Oncol; 2014 Sep; 134(3):576-80. PubMed ID: 25014539
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Diabetes and cancer: Could vitamin D provide the link?
    Ahmad S; Chowdhury TA; Boucher BJ
    J Diabetes Complications; 2013; 27(2):184-90. PubMed ID: 23164631
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Association between the TCF7L2 polymorphism and colorectal cancer does not differ by diabetes and obesity statuses.
    Shim HJ; Lee R; Shin MH; Kim HN; Kweon SS
    Cancer Epidemiol; 2016 Dec; 45():108-111. PubMed ID: 27792933
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Metabolic syndrome: a novel high-risk state for colorectal cancer.
    Ishino K; Mutoh M; Totsuka Y; Nakagama H
    Cancer Lett; 2013 Jun; 334(1):56-61. PubMed ID: 23085010
    [TBL] [Abstract][Full Text] [Related]  

  • 57. [The occurrence and impact on survival of type 2 diabetes mellitus and thrombocytosis in colorectal cancer, before and after the surgical resection of the primary tumor].
    Herold Z; Ambrus V; Herold M; Herczeg G; Igaz P; Harsányi L; Somogyi A
    Orv Hetil; 2018 May; 159(19):756-767. PubMed ID: 29730943
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impaired glucose metabolism in colorectal cancer.
    Ehrmann-Jósko A; Siemińska J; Górnicka B; Ziarkiewicz-Wróblewska B; Ziółkowski B; Muszyński J
    Scand J Gastroenterol; 2006 Sep; 41(9):1079-86. PubMed ID: 16938722
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis.
    Singh S; Singh H; Singh PP; Murad MH; Limburg PJ
    Cancer Epidemiol Biomarkers Prev; 2013 Dec; 22(12):2258-68. PubMed ID: 24042261
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Obesity paradox: differential effects on cancer and noncancer mortality in patients with type 2 diabetes mellitus.
    Tseng CH
    Atherosclerosis; 2013 Jan; 226(1):186-92. PubMed ID: 23040832
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.